Yasushi Imamura

1.5k total citations
51 papers, 1.3k citations indexed

About

Yasushi Imamura is a scholar working on Clinical Biochemistry, Epidemiology and Molecular Biology. According to data from OpenAlex, Yasushi Imamura has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Clinical Biochemistry, 12 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Yasushi Imamura's work include Metabolism and Genetic Disorders (16 papers), Liver Disease Diagnosis and Treatment (11 papers) and Amino Acid Enzymes and Metabolism (8 papers). Yasushi Imamura is often cited by papers focused on Metabolism and Genetic Disorders (16 papers), Liver Disease Diagnosis and Treatment (11 papers) and Amino Acid Enzymes and Metabolism (8 papers). Yasushi Imamura collaborates with scholars based in Japan and United States. Yasushi Imamura's co-authors include Takeyori Saheki, Takuya Hiwaki, Yoshirou Baba, Katsumi Sako, Masahisa Horiuchi, Gen Tanabe, Shinichi Ueno, Takashi Aikou, H. Hokotate and Yoshihiko Fukukura and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Cancer.

In The Last Decade

Yasushi Imamura

50 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasushi Imamura Japan 19 451 395 368 335 225 51 1.3k
Yung‐Hsiung Lai Taiwan 19 158 0.4× 255 0.6× 102 0.3× 272 0.8× 171 0.8× 43 1.2k
Bennett L. Blitzer United States 15 270 0.6× 124 0.3× 193 0.5× 235 0.7× 79 0.4× 25 1.3k
Elena Duner Italy 20 262 0.6× 103 0.3× 209 0.6× 324 1.0× 492 2.2× 50 1.5k
J. Ch. Bode Germany 11 378 0.8× 71 0.2× 154 0.4× 214 0.6× 142 0.6× 29 852
Cristina Robaudo Italy 20 108 0.2× 381 1.0× 55 0.1× 242 0.7× 376 1.7× 57 1.3k
T. Rietveld Netherlands 18 195 0.4× 55 0.1× 172 0.5× 164 0.5× 275 1.2× 36 973
Elisabeth Lasnier France 15 464 1.0× 42 0.1× 329 0.9× 107 0.3× 222 1.0× 36 1.0k
Serkan Tapan Türkiye 25 486 1.1× 74 0.2× 86 0.2× 285 0.9× 214 1.0× 81 1.5k
Masaki Takayanagi Japan 23 85 0.2× 623 1.6× 63 0.2× 588 1.8× 195 0.9× 78 1.3k
Hisashi Ozasa Japan 22 86 0.2× 263 0.7× 105 0.3× 627 1.9× 99 0.4× 45 1.1k

Countries citing papers authored by Yasushi Imamura

Since Specialization
Citations

This map shows the geographic impact of Yasushi Imamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasushi Imamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasushi Imamura more than expected).

Fields of papers citing papers by Yasushi Imamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasushi Imamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasushi Imamura. The network helps show where Yasushi Imamura may publish in the future.

Co-authorship network of co-authors of Yasushi Imamura

This figure shows the co-authorship network connecting the top 25 collaborators of Yasushi Imamura. A scholar is included among the top collaborators of Yasushi Imamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasushi Imamura. Yasushi Imamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshimura, T, Hajime Suzuki, Takayuki Ishida, et al.. (2022). Prognostic value of inflammatory biomarkers in aged patients with oral squamous cell carcinoma. Frontiers in Pharmacology. 13. 996757–996757. 10 indexed citations
2.
Uto, Hirofumi, Seiichi Mawatari, Shuji Kanmura, et al.. (2020). Impact of acute kidney injury on prognosis and the effect of tolvaptan in patients with hepatic ascites. Journal of Gastroenterology. 56(1). 54–66. 10 indexed citations
3.
Uto, Hirofumi, Seiichi Mawatari, Shuji Kanmura, et al.. (2019). Effect of tolvaptan on the prognosis of patients with hepatic ascites. Hepatology Research. 49(7). 765–777. 16 indexed citations
5.
Imamura, Yasushi, Hirofumi Uto, Hironori Miyahara, et al.. (2013). Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population. Journal of Gastroenterology. 49(10). 1406–1413. 12 indexed citations
6.
Uto, Hirofumi, Yasushi Imamura, Tomomi Kuwahara, et al.. (2012). Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol. Diabetology & Metabolic Syndrome. 4(1). 34–34. 15 indexed citations
7.
Uto, Hirofumi, Yasushi Imamura, Ken Kusano, et al.. (2011). Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. Journal of Gastroenterology. 46(6). 769–778. 117 indexed citations
8.
UDA, Takaaki, et al.. (2011). BEACH CHANGES AROUND ARTIFICIAL HEADLANDS ON ICHINOMIYA COAST. Journal of Japan Society of Civil Engineers Ser B3 (Ocean Engineering). 67(2). I_1224–I_1229. 3 indexed citations
9.
Kuroda, Naoto, Ondřej Hes, Michael Michal, et al.. (2008). Mucinous tubular and spindle cell carcinoma with Fuhrman nuclear grade 3: a histological, immunohistochemical, ultrastructural and FISH study.. PubMed. 23(12). 1517–23. 34 indexed citations
11.
Saheki, Takeyori, et al.. (1997). Abnormal Gene Expression Causing Hyperammonemia in Carnitine-Deficient Juvenile Visceral Steatosis (JVS) Mice. Advances in experimental medicine and biology. 420. 159–172. 4 indexed citations
12.
Inoue, Takayoshi, et al.. (1994). [A case of PIVKA-II and AFP producing gastric carcinoma].. PubMed. 91(1). 84–8. 5 indexed citations
13.
Kuwajima, Masamichi, Norio Kôno, Masahisa Horiuchi, et al.. (1991). Animal model of systemic carnitine deficiency: Analysis in C3H-H-2° strain of mouse associated with juvenile visceral steatosis. Biochemical and Biophysical Research Communications. 174(3). 1090–1094. 80 indexed citations
14.
Yoshimura, Yuichi, et al.. (1988). Double pylorus accompanied by gastric ulcer resistant to H2-receptor antagonist--a case report and review of the literature.. PubMed. 34(4). 151–9. 3 indexed citations
15.
Saheki, Takeyori, Keiko Kobayashi, Hitoshi Ichiki, et al.. (1987). Molecular Basis of Enzyme Abnormalities in Urea CycleDisorders. Enzyme. 38(1-4). 227–232. 22 indexed citations
16.
Imamura, Yasushi, et al.. (1986). Metabolic Fate of Batroxobin in Human. YAKUGAKU ZASSHI. 106(4). 335–342. 3 indexed citations
17.
Kobayashi, K., Takeyori Saheki, Yasushi Imamura, et al.. (1986). Messenger RNA coding for argininosuccinate synthetase in citrullinemia.. PubMed. 38(5). 667–80. 36 indexed citations
18.
Takahashi, Kazuo, et al.. (1983). Modification of batroxobin with poly ethylene glycol reduction of immuno reactivity towards antibody and retention of de fibrinogenation activity in circulation of pre immunized dogs. Thrombosis and Haemostasis. 50(1). 205. 2 indexed citations
20.
Saheki, Takeyori, Yasushi Imamura, Ikuo Inoue, et al.. (1983). Molecular basis of ornithine transcarbamylase deficiency lacking enzyme protein. Journal of Inherited Metabolic Disease. 7(1). 2–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026